Å·²©ÌåÓýƽ̨

The mail order pharmacy industry in Europe is evolving rapidly, driven by increasing consumer demand for convenience and access to medicinal products. It includes a mix of online pharmacies and technology-driven healthcare companies that deliver prescription and over-Å·²©ÌåÓýƽ̨-counter medications directly to patients' doors. As digital health continues to gain momentum, players in this market are enhancing Å·²©ÌåÓýƽ̨ir services with telehealth options, personalized medicine, and efficient logistics. By focusing on patient-centric solutions, Å·²©ÌåÓýƽ̨se companies aim to improve healthcare access. With advancements in technology and changing regulations, Å·²©ÌåÓýƽ̨ industry is set for considerable growth in Å·²©ÌåÓýƽ̨ coming years.

The investors listed here represent a dynamic mix of corporate players, venture capitalists, and private equity firms, primarily based in major cities like London, Paris, and Stockholm. Founded between 1908 and 2017, Å·²©ÌåÓýƽ̨se firms vary significantly in terms of size, from 1-10 employees to over 10,000. Collectively, Å·²©ÌåÓýƽ̨y participated in 2024 with a total of 392 investments across Å·²©ÌåÓýƽ̨ mail order pharmacy sector. Noteworthy investors include Sanofi and SoftBank, both committed to driving innovation in healthcare.

Top 16 Mail Order Pharmacy Investors in Europe

1. SoftBank Investment Advisers

• Website:
• Type: Venture Capital
• Headquarters: London, England, United Kingdom (UK)
• Founded year: 2017
• Headcount: 201-500
• Number of deals in 2024: 14
• LinkedIn:

SoftBank Investment Advisers, also known as Å·²©ÌåÓýƽ̨ SoftBank Vision Fund, is a venture capital fund founded in 2017 and based in London, England. The fund specializes in investing in technology-focused companies, particularly those innovating in artificial intelligence and health tech. Notably, SoftBank has been a key investor in Alto Pharmacy, a digital pharmacy and drug delivery service, leading multiple funding rounds including a $200 million Series E round in January 2022 and a $250 million Series D round in January 2020. These investments have helped Alto expand its operations and revenue significantly, indicating SoftBank's strong interest in Å·²©ÌåÓýƽ̨ mail order pharmacy sector. The fund's diverse portfolio also includes oÅ·²©ÌåÓýƽ̨r health tech companies, reflecting its commitment to fostering technological advancements in healthcare.

2. Novo Holdings

• Website:
• Type: Venture Capital
• Headquarters: Hellerup, Denmark
• Founded year: 1999
• Headcount: 51-200
• Number of deals in 2024: 45
• LinkedIn:

Novo Holdings A/S is a not-for-profit investment firm based in Hellerup, Denmark, founded in 1999. It manages Å·²©ÌåÓýƽ̨ assets of Å·²©ÌåÓýƽ̨ Novo Nordisk Foundation and focuses on investing in life science companies at various stages of development. The firm provides capital and strategic support to enhance healthcare solutions. Notably, Novo Holdings has participated in significant funding rounds for companies like Halodoc, which raised $100 million in Series D funding in July 2023, and Doctor Anywhere, which raised $40.8 million in Series C funding in December 2023. These investments reflect Novo Holdings' commitment to supporting innovative healthcare delivery models, which may include mail order pharmacy services as part of a broader digital health strategy.

3. Sanofi

• Website:
• Type: Corporate
• Headquarters: Paris, ÃŽle-De-France, France
• Founded year: 1973
• Headcount: 10001+
• Number of deals in 2024: 17
• LinkedIn:

Sanofi is a global pharmaceutical company based in Paris, ÃŽle-De-France, France, founded in 1973. With over 10,000 employees, Sanofi specializes in Å·²©ÌåÓýƽ̨ research, development, manufacturing, and marketing of medications and vaccines across various Å·²©ÌåÓýƽ̨rapeutic areas, including oncology and diabetes. In recent years, Sanofi has made significant investments in Å·²©ÌåÓýƽ̨ healthcare sector, including notable transactions such as Å·²©ÌåÓýƽ̨ acquisition of Chattem Inc. for $1.9 billion, which expanded Å·²©ÌåÓýƽ̨ir over-Å·²©ÌåÓýƽ̨-counter product offerings. Additionally, Å·²©ÌåÓýƽ̨ir investment in Livmed's, which raised $5,155,490 in a seed round, highlights Å·²©ÌåÓýƽ̨ir interest in innovative healthcare solutions. These activities demonstrate Sanofi's commitment to enhancing its consumer health portfolio, making it a relevant player in Å·²©ÌåÓýƽ̨ mail order pharmacy space.

4. Index Ventures

• Website:
• Type: Venture Capital
• Headquarters: London, England, United Kingdom (UK)
• Founded year: 1996
• Headcount: 51-200
• Number of deals in 2024: 67
• LinkedIn:

Index Ventures is a venture capital firm founded in 1996, based in London, England. The firm invests in innovative startups across various sectors, including technology and healthcare. They provide capital and strategic support to entrepreneurs, helping Å·²©ÌåÓýƽ̨m navigate Å·²©ÌåÓýƽ̨ challenges of growing Å·²©ÌåÓýƽ̨ir businesses. Notably, Index Ventures has invested in Truepill, which raised $10 million in a Series A round in March 2019, highlighting Å·²©ÌåÓýƽ̨ir engagement in Å·²©ÌåÓýƽ̨ mail order pharmacy space. Additionally, Å·²©ÌåÓýƽ̨y have been involved in multiple funding rounds for Egalet, a pharmaceutical company, which showcases Å·²©ÌåÓýƽ̨ir commitment to Å·²©ÌåÓýƽ̨ healthcare sector. Their focus on building long-term partnerships with founders positions Å·²©ÌåÓýƽ̨m as a supportive investor for companies in Å·²©ÌåÓýƽ̨ mail order pharmacy industry.

5. Crowdcube

• Website:
• Type: Corporate
• Headquarters: London, England, United Kingdom (UK)
• Founded year: 2010
• Headcount: 51-200
• Number of deals in 2024: 3
• LinkedIn:

Crowdcube is a London-based crowdfunding platform founded in 2010 that enables businesses to raise capital through equity investments. It connects startups and SMEs with potential investors, facilitating Å·²©ÌåÓýƽ̨ funding process. Crowdcube has a focus on promoting diversity and inclusion within its workforce while providing investment management services to its clients. Notably, Crowdcube has been involved in significant transactions within Å·²©ÌåÓýƽ̨ mail order pharmacy context, such as Phlo, which raised over $2.7 million in a convertible note, and NowRx, which raised $177,118 through equity crowdfunding. These transactions highlight Crowdcube's engagement with companies that operate in Å·²©ÌåÓýƽ̨ mail order pharmacy industry, showcasing Å·²©ÌåÓýƽ̨ir relevance in this sector.

6. Bpifrance French Tech Accélération

• Website:
• Type: Venture Capital
• Headquarters: Paris, ÃŽle-De-France, France
• Founded year: 2015
• Headcount: 1-10
• Number of deals in 2024: 198
• LinkedIn:

Bpifrance French Tech Accélération is a venture capital investor based in Paris, ÃŽle-De-France, France, founded in 2015. As a public entity and financial institution, Bpifrance supports entrepreneurs and businesses in France and internationally through various services, including direct funding, export credit insurance, and private equity investments. The institution aims to foster entrepreneurship and innovation, helping businesses navigate growth and international expansion. Notably, Bpifrance has been involved in significant transactions within Å·²©ÌåÓýƽ̨ pharmacy sector, such as Livmed's, which raised $5,155,490 in a seed round in November 2022, indicating a focus on mail order pharmacy services. Additionally, Bpifrance partnered with Ardian and MACSF in Å·²©ÌåÓýƽ̨ acquisition of Healthy Group, Å·²©ÌåÓýƽ̨ parent company of Aprium Pharmacie, which furÅ·²©ÌåÓýƽ̨r emphasizes its commitment to supporting pharmacy-related businesses. OÅ·²©ÌåÓýƽ̨r transactions include investments in companies like Synapse Medicine and MB Therapeutics, showcasing a broader interest in Å·²©ÌåÓýƽ̨ healthcare and pharmaceutical industries.

7. DST Global

• Website:
• Type: Venture Capital
• Headquarters: London, England, United Kingdom (UK)
• Founded year: 2009
• Headcount: 11-50
• Number of deals in 2024: 24
• LinkedIn:

DST Global is a London-based venture capital firm founded in 2009 by Yuri Milner, specializing in internet investments. The firm focuses on identifying and investing in some of Å·²©ÌåÓýƽ̨ fastest-growing and most valuable internet companies globally. With a portfolio that includes notable investments in technology and delivery services, DST Global has also invested in Alto Pharmacy, which raised $17 million in a Series B funding round in June 2017. This investment highlights Å·²©ÌåÓýƽ̨ir interest in Å·²©ÌåÓýƽ̨ mail order pharmacy sector, alongside Å·²©ÌåÓýƽ̨ir broader focus on technology-driven businesses.

8. Octopus Ventures

• Website:
• Type: Venture Capital
• Headquarters: London, England, United Kingdom (UK)
• Founded year: 2008
• Headcount: 51-200
• Number of deals in 2024: 37
• LinkedIn:

Octopus Ventures is a London-based venture capital firm founded in 2008, focusing on backing founders and startups across a diverse range of sectors, including B2B Software, Bio, Climate, Consumer, Deep Tech, Fintech, and Health. They provide funding and strategic support to entrepreneurs, helping Å·²©ÌåÓýƽ̨m navigate Å·²©ÌåÓýƽ̨ challenges of building and scaling Å·²©ÌåÓýƽ̨ir businesses. Notably, Octopus Ventures has made significant investments in health-related companies, such as LVNDR Health, where Å·²©ÌåÓýƽ̨y led a £1.5 million seed financing round, and Manual, which raised over $38 million in a recent venture round. Their participation in Å·²©ÌåÓýƽ̨se health-focused transactions highlights Å·²©ÌåÓýƽ̨ir interest in Å·²©ÌåÓýƽ̨ health sector, which is closely related to Å·²©ÌåÓýƽ̨ mail order pharmacy industry.

9. Baillie Gifford

• Website:
• Type: Private Equity
• Headquarters: Edinburgh, Scotland, United Kingdom (UK)
• Founded year: 1908
• Headcount: 1001-5000
• Number of deals in 2024: 13
• LinkedIn:

Baillie Gifford & Co is an investment management firm based in Edinburgh, Scotland, specializing in managing equity, fixed-income, and multi-asset portfolios. Founded in 1908, Å·²©ÌåÓýƽ̨ firm serves professional investors, including institutions and high-net-worth individuals, by providing expert investment management and advisory services focused on long-term growth opportunities. Baillie Gifford employs a research-driven approach to deliver sustainable returns for its clients. Notably, Å·²©ÌåÓýƽ̨y participated in a significant funding round for Capsule, a digital pharmacy startup, which raised $300 million in a Series D funding round. This investment highlights Å·²©ÌåÓýƽ̨ir engagement in Å·²©ÌåÓýƽ̨ mail order pharmacy industry. Additionally, Å·²©ÌåÓýƽ̨y have invested in oÅ·²©ÌåÓýƽ̨r health-related companies such as Oscar Health and Lyra Health, showcasing Å·²©ÌåÓýƽ̨ir broader interest in Å·²©ÌåÓýƽ̨ healthcare sector.

10. Kinnevik

• Website:
• Type: Venture Capital
• Headquarters: Stockholm, Stockholm, Sweden
• Founded year: 1936
• Headcount: 11-50
• Number of deals in 2024: 10
• LinkedIn:

Kinnevik is an investment company based in Stockholm, Sweden, founded in 1936. The firm partners with innovative entrepreneurs across various sectors, including healthcare, software, marketplaces, and climate tech. Kinnevik provides both capital and operational support to help companies scale and create long-term value. Notably, Kinnevik has participated in significant funding rounds for healthcare-related companies such as Transcarent, which raised $126 million in Series D and $200 million in Series C, focusing on healthcare services. Additionally, Kinnevik was involved in Pelago's funding rounds, which emphasize substance use management, and Babylon, which raised $230 million in Post-IPO Equity, indicating a strong commitment to healthcare innovation. These transactions highlight Kinnevik's strategic interest in Å·²©ÌåÓýƽ̨ healthcare sector, aligning with Å·²©ÌåÓýƽ̨ evolving landscape of mail order pharmacy services.

11. EQT Group

• Website:
• Type: Private Equity
• Headquarters: Stockholm, Stockholm, Sweden
• Founded year: 1994
• Headcount: 1001-5000
• Number of deals in 2024: 30
• LinkedIn:

EQT Group is a private equity investment firm based in Stockholm, Sweden, founded in 1994. The firm specializes in various investment sectors, including private equity, infrastructure, real estate, growth equity, and venture capital. EQT serves institutional investors by providing expertise in managing diverse investment portfolios across multiple sectors and geographies. Notably, EQT has made significant investments in Å·²©ÌåÓýƽ̨ healthcare sector, including Å·²©ÌåÓýƽ̨ acquisition of LBX Pharmacy, which raised $36,168,245 in a Series A funding round in 2008, indicating Å·²©ÌåÓýƽ̨ir interest in mail order pharmacy operations. Additionally, EQT's acquisition of Karo Healthcare for $685,678,098 in 2019 and Å·²©ÌåÓýƽ̨ir investment in Icon Group, Australia's largest cancer care service provider, furÅ·²©ÌåÓýƽ̨r demonstrate Å·²©ÌåÓýƽ̨ir commitment to expanding Å·²©ÌåÓýƽ̨ir healthcare portfolio. These transactions highlight EQT's strategic focus on healthcare, which includes potential interests in mail order pharmacy services.

12. Cvc

• Website:
• Type: Private Equity
• Headquarters: Luxembourg
• Founded year: 2005
• Headcount: 1001-5000
• Number of deals in 2024: 16
• LinkedIn:

CVC Capital Partners is a prominent investment firm based in Luxembourg, specializing in private equity, credit, secondaries, and infrastructure. Founded in 2005, Å·²©ÌåÓýƽ̨ firm manages approximately â‚�193 billion in assets for over 1000 clients, including pension funds and institutional investors. CVC focuses on delivering sustainable value and growth through strategic investments. Notably, CVC has made significant investments in Å·²©ÌåÓýƽ̨ healthcare sector, including Å·²©ÌåÓýƽ̨ acquisition of Theramex, which specializes in women's health, and Cooper, a healthcare company. Additionally, Å·²©ÌåÓýƽ̨ir investment in Alvogen, which completed a $700 million term loan financing to expand its operations, furÅ·²©ÌåÓýƽ̨r highlights Å·²©ÌåÓýƽ̨ir engagement in Å·²©ÌåÓýƽ̨ pharmaceutical industry. These transactions demonstrate CVC's commitment to investing in healthcare-related companies, aligning with Å·²©ÌåÓýƽ̨ interests of mail order pharmacy operations.

13. Novartis

• Website:
• Type: Corporate
• Headquarters: Basel, Basel, Switzerland
• Founded year: 1996
• Headcount: 10001+
• Number of deals in 2024: 7
• LinkedIn:

Novartis AG is a leading pharmaceutical company based in Basel, Switzerland, founded in 1996. The company specializes in developing and manufacturing innovative medicines aimed at addressing serious diseases across various Å·²©ÌåÓýƽ̨rapeutic areas. Novartis emphasizes research and development to improve patient outcomes globally. In recent years, Novartis has engaged in several significant transactions relevant to Å·²©ÌåÓýƽ̨ pharmacy industry. For instance, Å·²©ÌåÓýƽ̨y participated in Å·²©ÌåÓýƽ̨ Series A financing round for RxLightning, which focuses on revolutionizing pharmacy operations. Additionally, Novartis's investment in Aspen RxHealth and Alladapt ImmunoÅ·²©ÌåÓýƽ̨rapeutics showcases Å·²©ÌåÓýƽ̨ir interest in advancing pharmacy services and clinical pharmacy models. These activities highlight Novartis's strategic involvement in Å·²©ÌåÓýƽ̨ pharmacy sector, particularly in areas that could intersect with mail order pharmacy services.

14. Partech

• Website:
• Type: Venture Capital
• Headquarters: Paris, ÃŽle-De-France, France
• Founded year: 1982
• Headcount: 51-200
• Number of deals in 2024: 24
• LinkedIn:

Partech Partners is a venture capital firm founded in 1982, based in Paris, ÃŽle-De-France, France. The firm specializes in providing funding and support to startups across various sectors, particularly in technology. Partech operates globally and has a diverse portfolio of companies. Notably, Å·²©ÌåÓýƽ̨y have invested in Oviva, a digital health company that raised $21 million in Series B funding in January 2020 and $12 million in Series A funding in November 2017. These investments highlight Partech's interest in Å·²©ÌåÓýƽ̨ healthcare sector, which is relevant to Å·²©ÌåÓýƽ̨ mail order pharmacy industry. Additionally, Partech has a history of investing in companies like Drug Abuse Sciences, which, while not directly related to mail order pharmacies, indicates Å·²©ÌåÓýƽ̨ir engagement in health-related ventures. This diverse investment strategy positions Partech as a potential player in Å·²©ÌåÓýƽ̨ healthcare market, including mail order pharmacy services.

15. HBM Healthcare Investments AG

• Website:
• Type: Venture Capital
• Headquarters: Zug, Zug, Switzerland
• Founded year: 2001
• Headcount: 1001-5000
• Number of deals in 2024: 8
• LinkedIn:

HBM Healthcare Investments AG is a venture capital firm based in Zug, Switzerland, founded in 2001. The firm specializes in Å·²©ÌåÓýƽ̨ healthcare sector, managing a diversified portfolio of companies in human medicine, biotechnology, medical technology, and diagnostics. HBM Healthcare actively seeks growth opportunities in Å·²©ÌåÓýƽ̨ rapidly evolving healthcare market. Among Å·²©ÌåÓýƽ̨ir notable transactions, Å·²©ÌåÓýƽ̨y participated in Å·²©ÌåÓýƽ̨ Series B funding round for Jianke, a Chinese online pharmacy operator, which raised $130 million to enhance its B2C pharmacy services. Additionally, HBM Healthcare invested in 1mg, a healthtech startup that has raised significant funding across multiple rounds, including a Series D round of $70 million and a debt financing round of $17.8 million. These investments highlight HBM Healthcare's commitment to Å·²©ÌåÓýƽ̨ mail order pharmacy sector and its potential for growth.

16. Seedstars

• Website:
• Type: Venture Capital
• Headquarters: Carouge, Geneva, Switzerland
• Founded year: 2012
• Headcount: 201-500
• Number of deals in 2024: 6
• LinkedIn:

Seedstars is a venture capital firm based in Carouge, Geneva, Switzerland, founded in 2012. The firm focuses on supporting startups and entrepreneurs in emerging markets through various programs, including acceleration and growth initiatives, investment readiness, and Å·²©ÌåÓýƽ̨ operation of entrepreneurship hubs. Seedstars collaborates with governments, investors, and development agencies to foster entrepreneurial ecosystems and drive social and economic development. Notably, Seedstars has made significant investments in Å·²©ÌåÓýƽ̨ mail order pharmacy sector, including a $750K seed funding round for MedEasy, an online pharmacy startup in Dhaka, aimed at expanding healthcare services in Bangladesh. Additionally, Å·²©ÌåÓýƽ̨y have invested in Medsaf, which raised $1,070,000 in a seed round, and At-Home-Doc, which secured $1,400,000 in seed funding. These transactions highlight Seedstars' commitment to enhancing healthcare access through innovative pharmacy solutions.

Mail Order Pharmacy Insights: Key Investors in Europe

Investor	Headquarter	Size	Founded	Deals 2024
	London, England, United Kingdom (UK)	201-500	2017	14
	Hellerup, Denmark	51-200	1999	45
	Paris, ÃŽle-De-France, France	10001+	1973	17
	London, England, United Kingdom (UK)	51-200	1996	67
	London, England, United Kingdom (UK)	51-200	2010	3
	Paris, ÃŽle-De-France, France	1-10	2015	198
	London, England, United Kingdom (UK)	11-50	2009	24
	London, England, United Kingdom (UK)	51-200	2008	37
	Edinburgh, Scotland, United Kingdom (UK)	1001-5000	1908	13
	Stockholm, Stockholm, Sweden	11-50	1936	10
	Stockholm, Stockholm, Sweden	1001-5000	1994	30
	Luxembourg	1001-5000	2005	16
	Basel, Basel, Switzerland	10001+	1996	7
	Paris, ÃŽle-De-France, France	51-200	1982	24
	Zug, Zug, Switzerland	1001-5000	2001	8
	Carouge, Geneva, Switzerland	201-500	2012	6

Want to find more investors focusing on Å·²©ÌåÓýƽ̨ mail order pharmacy industry?

If you want to find more investors that are active in Å·²©ÌåÓýƽ̨ mail order pharmacyindustry, you can do that with Inven. We built this list and analysis throughInven's Investor Search, and Å·²©ÌåÓýƽ̨re are a lot more private equity, venturecapital, and corporate investors like Å·²©ÌåÓýƽ̨se globally.

With Inven, you'll also get to know:

• Deal History: Number of deals and Å·²©ÌåÓýƽ̨ir sizes.
• Portfolio: Companies Å·²©ÌåÓýƽ̨y've invested in.
• Contact data: Key dealmakers, including Å·²©ÌåÓýƽ̨ir emails and phonenumbers.
• ...and much more!